Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic, UCB Pharma Expand 1999 Collaboration

NEW YORK, Sept. 6 – Gene Logic has licensed a pair of its technology platforms and a set of gene targets to a business unit of Belgian drug company UCB Pharma, the companies said on Thursday.

Under the deal, which broadens an existing collaboration inked in 1999, UCB Research, of Cambridge, Mass., will gain access to the BioExpress Module of Gene Logic’s GeneExpress suite plus the Genesis Enterprise System, according to a statement.

UCB also has bought an exclusive license to allergy and asthma gene targets and gene-expression data culled form the firms’ original deal, they said.

Financial terms of this recent collaboration were not disclosed. However, the companies said that Gaithersburg, Md.-based Gene Logic “will recognize multi-year revenue” from the two new licensing agreements, as well as “one time revenue” for the gene-targets and -expression data.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.